Cryptorchidism and Steroid Hormones by Marzena Kamieniczna et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
4 
Cryptorchidism and Steroid Hormones 
Marzena Kamieniczna1, Anna Havrylyuk2 and Maciej Kurpisz1 
1Institute of Human Genetics Polish Academy of Sciences, 
2Danylo Halytsky Lviv National Medical University,  
Department of Clinical Immunology and Allergology, 
1Poland 
2Ukraine 
1. Introduction 
Two important functions of testis are production of spermatozoa and synthesis of steroids. 
These functions depend on anatomical, hormonal and constitutional homeostasis and begin 
during the first stage of gestation. Cryptorchidism can be defined as an abnormal 
localization of one or both testes. It’s the failure of one or both testes descent into the scrotal 
sac. The third trimester in humans is crucial for the testis descent. When the testis is not 
found in normal location it may be palpable or nonpalpable. The palpable testis may be 
cryptorchid, ectopic or retractile. Non-palpable testis may be cryptorchid, atrophic or  
absent. Cryptorchidism occurs when the testis fails to descend into its normal postnatal 
location and may be found in the abdomen, in the inguinal canal or just reaching the 
external ring (prescrotal) (Nguyen 1999). Before sex determination, both female and male 
embryonic gonads are located in the same high intra-abdominal position. During 
mammalian development, the cranial suspensory ligament (CLS) and the caudal ligament 
(or gubernaculum) is responsible for a sexual dimorphic position of the testis and ovary. In 
males, regression of the CLS, along with the outgrowth of the gubernaculum and its 
migration to the scrotum, results in the extraabdominal position of the testis (Agoulnik 2005). 
Androgens induce regression of the cranio-suspensory ligament to release the testis to 
descent. The inguinoscrotal descent of the normal testicle takes place between 26 and 35 
weeks of gestation. In preterm males with cryptorchidism the testes may descent postnatally 
(Berkowitz 1993, Cortez 2008). Cryptorchidism is one of the most common urogenital 
disorders in boys. Cryptorchidism can occur as an isolated disorder or may be associated 
with other congenital anomalies. The intraabdominal temperature is dangerous for germ 
cells and cryptorchidism may be a risk factor for male infertility and for testicular 
malignancy in adulthood. The decrement in intratesticular temperature in adult males is 2-
4ºC lower compared with body temperature (Thonneau 1998). This temperature difference 
is necessary to maintain spermatogenesis. The lower temperature in the scrotum is essential 
for normal spermatogenesis. Dangerous effects of increased temperature on 
spermatogenesis are well documented. For undescended testis abnormal spermatogenesis 
may be related with degenerative changes connected with high temperature (Mieussed 
1993). This condition affects both morphology and function of the Sertoli and Leydig cells of 
the testis (Farrer 1985) The association of cryptorchidism with testicular cancer is also well 
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documented (Giwercman 1989). The prevalence of cryptorchidism among boys is 2-4% in 
full - term male birth and 2-8.4% among boys with premature births. The incidence of 
cryptorchidism is significantly increased in premature males (Berkowitz 1993). Presently we 
observe an increased trend in the incidence of congenital cryptorchidism. Sometimes 
statistics includes testis in a high scrotal position (as normal descent) or cryptorchid testis 
may spontaneously descent in the first months after birth, therefore the incidence of 
cryptorchidism decreases from 1% to 0.5% by age of 1 year due to spontaneous descent 
(Barthold 2003). In earlier studies it has been speculated that the late spontaneous testicular 
descent occurs in more than half (Boisen 2004) or 70% of newborns with cryptorchidism. On 
the contrary the data obtained by Wenzler et al. (Wenzler 2004) showed that in patients with 
cryptorchidism spontaneous testicular descent occurs infrequently during the first year of 
life. They found that in patients with cryptorchidism before 12 months only 6.9% of the 
cryptorchid testicles reached the acceptable scrotal location at age of 1 year or later (Wenzler 
2004). There are large regional differences in incidence of cryptorchidism. The study on the 
prevalence of congenital cryptorchidism in Demmark and Finland was also performed and 
much higher incidence of congenital cryptorchidism in Denmark was found. In Denmark an 
increase in reproductive health problems is explained by environmental factors, including 
endocrine disrupters and a lifestyle (Boisen 2004). In the meantime the incidence of 
cryptorchidism has increased in many countries. In two comparable British studies the 
incidence of cryptorchidism delivered at term boys approximately doubled between the 
1950s and the 1980s. (Toppari 2001). However the report by Cortes (2008) has shown that the 
incidence of cryptorchidism in Denmark has not changed and is similar to the previous 
reports obtained in the 1950s. They have pointed out the general difficulties to compare the 
frequency of cryptorchidism as reported in different publications, since the definition of 
cryptorchidism is not yet uniform (Cortes 2008). The International Clearinghouse for Birth 
Defects Monitoring System has collected data on cryptorchidism, but they are unreliable, 
because of a discrepancy with the data from cohort studies (Toppari 2001). The present 
incidence may be even higher than reported one because of under-reporting tendency 
(Kaleva 2005).  
Cryptorchidism is a risk factor for male infertility in adulthood and for the male health 
(testicular cancer). Cryptorchidism uni- or bilateral is associated with degenerative changes 
in Sertoli cells and germ cells and is the most common etiologic factor of azoospermia 
(Hadziselmovic 2001). 89% of untreated cryptorchid patients with bilateral maldescent 
develop azoospermia and 32% treated medically or 46% boys treated surgically develop 
azoospermia (Hadziselimovic 2001). Hormonal treatment with human chorionic 
gonadotropin (HCG) or gonadotropin releasing hormone may be given initially for 
cryptorchidism. Very often a surgical intervention is needed to protect function of 
seminiferous tubules and to prevent degenerative changes in Sertoli and germ cells saving 
the man’s future fertility potential.  
2. Pathogenesis of cryptorchidism 
The etiology of cryptorchidism remains mostly unclear (Foresta 2008). The main risk factor 
is preterm birth, low birth weight, disrupted endocrine regulations, several gene defects and 
environmental factors (endocrine disruptors). Preterm birth and small size for gestational 
age are risk factors for cryptorchidism (Pierik 2004). Cryptorchidism is considered to be 
indirectly related to birth weight. The incidence of cryptorchidism is about 20-25% in infants 
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with birth weight less than 2.5 kg (Scorer 1964). Androgens play a crucial role in the 
development of male external genital organs and testicular descent. Hormonal 
dysregulation can be one out of many etiological factors of cryptorchidism (Suomi 2006). 
Testicular descent is at least partly dependent on fetal testicular testosterone, which in turn 
is initiated and maintained by human chorionic gonadotropin produced by the placenta 
(Biggs 2002). An increased risk of cryptorchidism in cases with placental abnormalities is 
noted (Biggs 2002). The increasing incidence of reproductive abnormalities in human males 
may be associated with increased estrogen exposure during gestation. The increased 
expression of estradiol in the syncytiotrophoblast may have impact on testicular descent 
(Hadziselmovic 2000). Industrial and agricultural chemicals acting as endocrine disrupters 
might have a deleterious effect on normal male sexual differentiation. These chemicals may 
occur in our close environments of work and life, drinking water, a food. Humans can also 
be exposed to natural phytoestrogens through consumption of food products derived from 
the plants (Toppari 1996, Sultan 2001). Various groups of chemicals, including pesticides 
and phthalate esters, have been identified as being weakly estrogenic or antiandrogenic 
(Sharpe 2003). Ferlin has proposed a distinction between intrinsic and extrinsic causes of 
cryptorchidism. In the first group frequenly displayed bilateral cryptorchidism is associated 
with progressive testicular damage and icreased risk of infertility or testicular damage. In 
these cases early orchidopexy may reduce the risk of these consequences but does not 
eliminate it definitely. Genetic alterations are more frequent in this group (Klinefelter 
syndrome, RXFP2 gene mutations) (Ferlin 2008). In the group with extrinsic causes of 
cryptorchidism (low birth weight, prematurity, maternal diabetes or preeclampsia during 
pregnancy) a spontaneous descent in the first months of age is noted. The early orchidpexy 
can reduce almost completely risk of testicular damage (Trisnar 2009). The possible genetic 
background of cryptorchidism still remains unresolved and genetics causes are rarely found 
(Ferlin 2008). 
The following genetic abnormalities may be associated with cryptorchidism: 
- - mutations in the gene coding for insulin-like factor 3, 
The mutation R102C was detected in a boy with unilateral persistent cryptorchidism (Ferlin 
2008). The other mutation (T86M) was detected in a boy with bilateral cryptorchidism and 
spontaneous descent in the first months of age (Ferlin 2008). 
- mutations in INSL3 receptor gene (RXFP2). 
- mutations in the gene coding for receptor for insulin-like factor 3, 
INSL3/LGR8, 
- mutations in the androgen receptor gene, 
- chromosomal alterations in Klinefelter syndrome. 
Familial occurrence – cryptorchidism is heritable susceptibility.  
Seasonal variation in the incidence of cryptorchidism suggest that environmental factors 
may have the importance in its etiology. Cryptorchidism can be often the consequence of 
testicular dysgenesis, a developmental disorder of the gonads due to disruption of 
embryonal programming and gonadal development during fetal life. Testicular dysgenesis 
syndrome (TSD) can result in maldescent, reduced fertility and an increased risk for 
malignant development, increased frequency of incomplete descent of a testis into the 
scrotum and hypospodias (Skakkebaek 2001). TSD can arise due to environmental factors 
including endocrine disrupters (potential endocrine disruptors in diet, in place of 
occupation; lifestyle, dietary phytoestrogens, present in food, water, air) or genetic defects. 
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The contalateral testis in men with unilateral testis cancer (Berthelsen 1983) or unilateral 
cryptorchidism (Kaki 1999) can be often damaged as well. There is also clear confirmation of 
testicular dysgenesis syndrome. Fetal exposure to endocrine disruptors (EDs) with estrogen-
like or antiandrogen-like activity has been suggested as a cause for TDS (Sharpe 1993). 
Environmental or genetic defects can influence Leydig cell function and result in androgen 
insufficiency which may cause testicular maldescent (Skakkebaek 2001).  
Uterine exposure to environmental endocrine disruptors can have also deleterious effects on 
male reproductive system development in embryos. Environmental endocrine disruptors 
(EEDs) are defined as exogenous substances witch can disrupt endocrine homeostasis and 
reproduction. EEDs include xenoestrogens, synthetic hormones, natural hormones or 
substances affecting endocrine signaling (Vidaeff 2005). 
Chemicals have been found to possess either weak estrogenic, anti-androgenic or other 
hormonal activities, which are often referred to as endocrine disrupters. Fetal or perinatal 
exposure to endocrine disrupters results in disturbed sexual differentiation, urogenital 
malformations and decreased reproductive health in adult life (Sharpe 1993).  
The significantly increased risk of bilateral cryptorchidism in boys whose mothers smoked 
heavily during pregnancy may indicate that heavy maternal smoking can be included in the 
pathogenesis of cryptorchidism (Throup 2005). Altered hormonal levels in smokers may 
have a casual role in cryptorchidism. Paternal pesticide exposure may be also associated 
with cryptorchidism. The investigation of circulating androgens bioactivity in 3-month-old 
boys suggests that infant boys are exposed to biological effects of androgens during the 
postnatal activation of the hypothalamic-pituitary-testicular axis, and the degree of the 
exposure may result in testis location superior to the scrotum (Raivio 2003) 
3. Hormonal regulation of testicular descent 
Testicular descent is hormonally regulated. Regulation of testicular descent is not yet 
completely understood. There are various forms of cryptorchidism (congenital with or 
without spontaneous descent, mild versus severe, acquired). These forms may reflect 
distinct hormonal patterns which differ in each situation (Suomi 2006). Apart from 
anatomical configuration and hormonal stimulation, genetic control of testis descent is very 
important. Major regulators of testicular descent are insulin-like factor 3 and testosterone. 
Testes migrate from initial intraabdominal position into the scrotal sac in two distinct 
hormonally regulated phases. During the first transabdominal phase (androgen 
independent) (10-23th week gestation) the CLS (cranial suspensory ligament) regresses while 
the gubernaculum shortens and develops caudal segment into the gubernaculum bulge. The 
second inguinoscrotal phase (depends on androgens) is normally completed by the 35th 
week – the gubernaculum extends caudally into the scrotum and involutes, following the 
passage of the testis through the inguinal canal. 
The first phase of testis descent (transabdominal) is regulated essentially by insulin-like 
factor 3 (INSL3), a peptide, product of the pre- and postnatal Leydig cells. INSL3 controls 
the passage through its receptor Lgr8 (leucine-rich-containing repeats G protein-coupled 
receptor). Genetic disruption of the Insl3 gene or its receptor (Lgr8) in mice has led to high 
intraabdominal cryptorchidism (Adham 2004). In the second phase (inguinoscrotal) 
androgens (testosterone) are the major mediators of testis descent (Foresta 2008). The 
inguinoscrotal phase is at least partly dependent on fetal testicular testosterone secretion, 
which in turn is initiated and maintained by human chorionic gonadotropin produced by 
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placenta. In mutation analysis of the human homologs of INSL3, LGR8 or HOXA10 genes in 
patients with cryptorchidism there were rarely found mutations or polymorphisms 
(Bogatcheva 2005, Bertini 2004). 
For a normal descent and testicular development of the testes, a normal hypothalamo-
pituitary-gonadal axis is essential. Certain androgens:estrogens ratio is required for 
physiological function of the testis. Steroid hormones act through specific receptors: ARs, 
ERǂ, ERǃ.  
Insl-3 is under estrogenic control. Mutations in ins-3 gene showed a low incidence at 1.3% in 
patients with cryptorchidism. Estrogens may affect insl-3 expression and may have a role in 
regulation of testicular descent (Tomboc, 2000).  
Androgen receptors (ARs) mediate the biological effects of both T and 5ǂ-
dihydrotestosterone. AR mutations are not a frequent cause of isolated cryptorchidism 
(Ashim 2004, Ferlin 2006, Ferlin 2008). AR mutations in men with history of cryptorchidism 
are connected rather with infertility. The AR is highly polymorphic due to a glutamine 
repeat (CAG) and a glycine repeat (GGN). Polymorphic CAG and GGN segments regulate 
AR function. A clear associations were observed between shorter CAG repeats and 
disorders dependent on enhanced androgen action. Longer CAG repeats have been 
associated with undescended testes, idiopathic hypospadias and decreased sperm counts. In 
result of combined analysis of CAG and GGC repeat lengths the stronger association with 
cryptorchidism was found (Ferlin 2005). The CAG repeat length has been also assessed in 
males with cryptorchidism, but no association between CAG repeat length and 
undescended testes was found in Japanese population (Sasagawa 2000) or Caucasian 
population (Aschim 2004). It was indicated rather association between GGN length and 
cryptorchidism or hypospadias (Aschim 2004). Median GGN lengths were significantly 
higher (24 vs. 23) among subjects with cryptorchidism, compared with controls and subjects 
with hypospadias. GGN length 23 is the most prevalent in males from general population. A 
majority of individuals with cryptorchidism demonstrated GGN numbers of 24 or more 
(Aschim 2004).  
4. Hypothalamic-pituitary-testicular axis 
Androgens regulate testicular descent, but androgen action alone is not sufficient for normal 
testicular descent. A proper hypothalamus-pituitary-testis axis function together with 
normal synthesis and action is a prerequisite for normal testicular descent. Various defects 
in this axis may result in cryptorchidism (Toppari 2007). Regulation of androgen production 
depends on hCG (placental human chorionic gonadotropin) and LH (pituitary luteinizing 
hormone) actions. INSL3 (insulin-like hormone-3) is the main regulator of gubernaculum 
development and testicular descent. Reduced levels of INSL3 may cause cryptorchidism 
(Toppari 2007). INSL3 production is also related to LH levels. Cryptorchid boys have 
normal testosterone and elevated LH levels (Toppari 2007). The first postnatal months of 
boys are characterized by activation of the hypothalamic-pituitary-testicular axis that results 
in the well depicted surge of reproductive hormones. Serum testosterone levels at that time 
are high, but infants do not display signs of virilization, and subsequently there is only 
indirect evidence that circulating androgens during the surge are biologically active. Three-
month-old boys are exposed to biological effects of androgens during the postnatal 
activation of the hypothalamic-pituitary-testicular axis, and this exposure may be reduced in 
boys with at least 1 testis located superior to the scrotum. Functional integrity of the HPG 
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axis is fundamental for testicular descent. Gonadotropin-releasing hormone (GnRH) 
regulates the production of pituitary gonadotropins FSH and LH. Gonadotropins FSH and 
LH are the main regulators of postnatal testicular activity. LH stimulates Leydig cells to 
produce testosterone while FSH regulates Sertoli cell functions (Toppari 2006). Human fetal 
testis binds hCG and physiological levels hCG stimulate testosterone production at least 
from 14 weeks of gestation (Huhtaniemi 1977). LH becomes more important regulator of 
fetal testosterone synthesis in the late pregnancy (Quinton 2001). The high percentage of 
cryptorchidism cases resolves spontaneously during the period of high serum gonadotropin 
and steroid hormone levels at the age of 1-3 months (Anderson 1998).  
Testosterone is one of the main regulators of testiculat descent. It is the main androgen in 
the circulation, mainly protein-bound, either strongly to sex hormone binding globulin 
(SHGB), or loosely to albumin. Only about 2% of this hormone is unbound; this is called free 
testosterone and is considered to be the most biologically active form of testosterone. In the 
target tissue testosterone can either bind directly to the androgen receptor (AR) or, if the 
tissue expresses the enzyme 5a-reductase, can be converted to dihydrotestosterone (DHT). 
Testosterone is produced by Leydig cells and low testosterone level is a consequence of a 
reduced ability of the Leydig cells to synthesize T.  
Impaired testosterone biosynthesis or distinct increase in testosterone metabolism is 
observed in cryptorchidism. Aromatase may convert androgens into estradiol. Testosterone 
is converted by aromatase CYP 19 to estradiol in many tissues of healthy men. The 
development of internal male genitalia is testosterone dependent, and 5ǂ-
dihydrotestosterone (synthesized from T by the enzyme 5ǂ-reductase 2) is essential for 
normal external masculinization. DHT is produced from circulating testosterone, which is 
manufactured by the fetal testis under stimulation of hCG.  
Estrogens Estrogens are necessary for maintaining functional integrity of the male 
reproductive tract. Estrogens and ERǂ are important for fertility. Excess of estrogens can 
affect function of the cells of male reproductive system. The excess of estrogens was 
reported to be associated with cryptorchidism, epididymal defects, impaired fertility. 
Estradiol however is an essential hormone for male reproduction. The maternal and 
placental estradiol is elevated in children with cryptorchidism. The increased expression of 
estradiol in the syncytiotrophoblast may have an impact on testicular descent 
(Hadziselmovic 2000). Low estrogen levels in mothers may mean that a placental defect 
increases the risk of cryptorchidism (Mc Glynn 2005). Estrogens are synthesized in the male 
reproductive system by at least four different cell types: Leydig cells, Sertoli cells, germ cells 
and epithelial cells of the epididymis. Estrogens are synthesized in a cortex of the adrenal 
gland, too. In the immature testis, the main source of estrogens are Sertoli cells. 
In horse and mouse in vivo cryptorchidism is associated with the increase in conversion of 
androgens to estrogens in the testis (Hejmej 2008), epididymal duct and the prostate. 
Increase in testosterone metabolism rather than an impairment of testosterone production is 
proposed to explain incidence of cryptorchidism. Testicular descent is significantly inhibited 
by estradiol. The estrogen effect might be mediated through suppression of fetal Leydig cell 
development, with resulting decrease of androgens and INSL3 production.  
5. Estrogen receptor α, ERs 
The association of cryptorchidism with a specific haplotype of the estrogen receptor 1 gene 
was reported (Yoshida 2005). The specific haplotype AGATA located within the 3’ end of 
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human ESRI1 is associated with cryptorchidism in the Japanese population. The AGATA 
haplotype was frequently found to be significant in cryptorchid children. Homozygosity for 
the AGATA haplotype was found only among cryptorchid boys (Yoshida 2005). ERǂ and 
PR (progesterone receptor) expressed in paratesticular tissues are important for normal 
testicular descent. ERǂ was overexpressed in boys with undescended testis previously 
treated with human chronic gonadotropin (Przewratil 2004).  
The analysis of the whole AGATA haplotype is possible by testing only the SNP12 (the tag 
SNP for the AGATA haplotype). Results obtained by Galan indicated that SNP 12 is the tag 
SNP for the AGATA haplotype also in Caucasians, but is not connected with 
cryptorchodism and infertility. Surprisingly ESR1 SNP12 may have a protective effect on 
cryptorchidism in the Italian populations, since it was found more frequently among 
healthy populations (Galan 2007).  
Progesterone influences spermiogenesis, sperm capacitation/acrosome reaction and 
testosterone biosynthesis in the Leydig cells. The detection of progesterone receptor (PR) 
isoforms have a diagnostic value in prostate cancer (Oettel 2004). The position of the 
undescended testis did not appear to influence progesterone metabolism (Läckgren 2008). 
PRs density was higher in paratesticular tissues (cremaster muscle and processus vaginalis) 
obtained from boys with undescended testis compared to the control group (Przewratil 
2005) 
6. Steroid hormones, male immune system and reproductive system 
Steroid hormones especially testosterone, progesteron and estradiol can modulate the 
immune system. The relationship between the immune system and reproduction is very 
strict. The immune response may be involved in reproductive processes what may interfere 
with fertility. A role of estrogens and testosterone in (auto)antibody production was proved. 
Estrogens increase, while testosterone decreases antibody production. Immune disorders 
have been formulated to take part in etiology of cryptorchidism. 
The significant associations of cryptorchidism with HLA class I antigens were found. Some 
associations of HLA class I alleles (HLA-A11, A23, A29) with cryptorchidism were 
explained by their crossreactivity with receptors for LH and hCG present on fetal Leydig 
cells and/or interference with the hormone-binding sites through a mechanism of 
“molecular mimicry” (Martinetti 1992). Most likely the ”molecular mimicry” between 
hormonal receptors and HLA surface antigens may also play a role in etiopathogenesis of 
cryptorchidism. The human major histocompatibility complex class II HLA molecules, by 
presenting antigens to helper T cells, play a decisive role in induction of antibody 
production (Chen 2008). Antisperm antibodies (AsA) in serum samples from prepubertal 
boys with testicular failure were substantially reported (Lenzi 1991, Kurpisz 1996, Sinisi 
1998). We have investigated the frequency of HLA class II alleles to recognize possible 
genetic predisposition for antisperm antibodies development in prepubertal boys with 
diagnosed cryptorchidism. We have found, a strong correlation between the presence of 
some HLA-antigens in patients with unilateral and bilateral cryptorchidism, and a formation 
of antisperm antibodies. We have observed that boys suffering from bilateral cryptorchidism 
differed from controls in their HLA-DRB1*11 frequency. Associations of cryptorchidism with 
some HLA-DRB1 and HLA-DQB1 alleles, very rare in Caucasians, were described only for a 
Japanese population (Tsuji 2000). No correlation with HLA class II polymorphism, however, 
was observed in a study of Italian population. We have observed strong difference between 
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cryptorchidism with history of infertility within these families and healthy controls, showing a 
high risk for HLA-DRB1*11 bearers. This result may suggest that sporadic and familial 
cryptorchidism may have different genetic background. HLA-DRB1*11 was also, albeit 
weakly, associated with bilateral cryptorchidism. Predisposition to produce anti-sperm 
antibodies seems to be only weakly associated with HLA class II genes.  
Autoimmune reactions, particular directed to testicular elements and/or spermatozoa have 
been found to be often associated with cryptorchidism. Antisperm immunization has been 
proposed as possible additional factor associated with late surgery in prepubertal boys with 
cryptorchidism. Cryptorchidism in young boys can induce immune reactions against sperm-
specific antigens. Future fertility status thus may be endangered, because antisperm 
antibodies can impair fertility at different levels. The relationship between the presence of 
antisperm antibodies and male infertility has been documented in large number of earlier 
studies (Krause 2009). There are some reports on high frequency of antisperm antibodies 
(AsA) in infertility patients who have suffered in the past from cryptorchidism. In healthy 
men seminiferous epithelium is anatomically sequestered from the systemic immunity. 
There exist multiple elements of active tolerance. An increased ability for induction of 
antisperm antibodies in men has been observed in various testicular pathologies: varicocele, 
testicular torsion, vasectomy and genital tract infections. An induction of antisperm 
antibodies in adult males may take place because of a break in the anatomical “blood-testis” 
barrier or because of the failure of an immunosuppressive mechanism providing tolerance 
to sperm. Sometimes, such antibodies can arise without a known reason. Pathologic 
conditions within the urogenital tract may predispose to antisperm antibody formation. In 
prepubertal boys, testicular failures may cause an activation of destructive to testes humoral 
immune response, because the anatomical testicular barrier is then not completely formed 
and immunosupression not fully activated due to the absence of male germ cells. 
Diminished levels of testosterone observed in prepubertal boys may be an additional reason 
for inefficient immunosupresion at young age and may contribute to the rise of 
autoantibody development (Jones 1994). It is difficult to argue whether it is mainly 
anatomical sequestration or rather active immunosuppresion playing a dominant role in 
preserving intact spermatogenic differentiation. It was earlier reported that 20-60% of 
individuals with a history of maldescended testis have circulating antisperm antibodies and 
most of them demonstrates oligoasthenozoospermia (Urry 1994). Evaluating the immune 
status of prepubertal boys with testicular failures, we have previously found detectable 
levels of AsA predominantly in boys with pathology of both gonads (Kurpisz 1996). One 
possible explanation for the induction of immune response to spermatozoa (testis) may be 
an increase of testicular temperature in boys with cryptorchidism, which may initiate the 
degenerative changes in spermatogenesis and alter testicular functions. A unique exposure 
of membrane antigens on testicular cells can be thus noted. Changes in the Leydig cells 
function may provoke the disturbances in the levels of locally secreted hormones, e.g. 
diminished levels of testosterone. Altogether, this multifactorial machinery may create a 
“vicious circle” that will perpetuate intratesticular inflammation leading to the inhibition of 
spermatogenesis that was to be triggered at the onset of puberty. 
7. Final remarks 
Cryptorchidism is one of the most common urogenital disorders found in postnatal boys. 
Main predisposing factor are: preterm birth, dysfunctional endocrine regulations, gene 
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defects and environmental factors (endocrine disruptions). It is believed that testicular 
descent is hormonally regulated and although genetic, contribution is observed, the number 
of genes/mutations responsible for testis descent is relatively rare. Changed environment in 
testis located in abdomen may induce pathological reactions mainly resulted in immune 
response induction. This, however, seems to be a secondary phenomenon. Despite this, once 
triggered immune response may persist and underlie future infertility in adulthood. Early 
surgical intervention in cryptorchidism can be therefore recommended.  
8. References 
Agoulnik, A.I. Cryptorchidism: An estrogen spoil? (2005). Journal of Clinical Endocrinology & 
Metabolism, 90, 4975-4977. 
Anderson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell. (1998). Longitudinal 
reproductive hormone profiles in infants: peak of inhibin B levels in infant boys 
exceeds levels in adult men. Journal of Clinical Endocrinology & Metabolism, 83, 675-
681. 
Aschim EL, Nordenskjöld A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB, Grotmol T 
Giwercman YL. (2004). Linkage between cryptorchidism, hypaspodias, and GGN 
repeat length in the androgen receptor gene. Journal of Clinical Endocrinology & 
Metabolism, 89, 5105-5109. 
Bartholg J, Gonzalez R. (2003). The epidemiology of congenital cryptorchidism, testicular 
ascent and orchidopexy. Journal of Urology, 170, 2396-2402. 
Bertini V, Bertelloni S, Valetto A, Lala R Foresta C, Simi P. (2004). Homeobox HOXA10 gene 
analysis in cryptorchidism. Journal of Pediatric Endocrinology & Metabolism, 17, 41-45. 
Bogatcheva NV, Agoulnik AI. (2005). INSL3/LGR8 role in testicular descent and 
cryptorchidism. Reproductive BioMedicine Online, 10, 49-54. 
Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, 
Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J. (2004). Difference 
in prevalence of congenital cryptorchidism in infants between two Nordic 
countries. Lancet, 363, 1264-1269. 
Chen X, Jensen PE. (2008). MHC class II antigen presentation and immunological 
abnormalities due to deficiency of MHC class II and its associated genes. 
Experimental and Molecular Pathology, 85: 40-44. 
Cortes D, Kjellberg EM, Breddam M, Thorup J. (2008). The true incidence of cryptorchidism 
in Denmark. Journal of Urolology, 179, 314-318. 
Domagała A, Kamieniczna M, Kurpisz M. (2000). Sperm antigens recognized by antisperm 
antibodies present in sera of infertile adults and prepubertal boys with testicular 
failure. International Journal of Andrology, 23; 150-155. 
El Houtate B, Rouba H, Sibai H, Barakat A, Chafik A, Chadli E, Imken L, Bogatheva N, Feng 
S, Agoulnik A, McElreavey K. (2007). Novel mutations involving the INSL3 gene 
associated with cryptorchidism. Journal of Urolology, 177, 1947-1951. 
Farrer JH, SikkaSC, Xie HW, Constantinide D, Raifer J. (1985). Impaired testosterone 
biosynthesis in cryptorchidism. Fertility and Sterility, 44, 125-132. 
FerlinA, Vinanzi C, Garolla A. (2006). Male infertility and androgen receptor gene 
mutations: clinical features and identification of seven novel mutations. Clinical 
Endocrinology, 65, 606-610.  
www.intechopen.com
 
Steroids – Basic Science 
 
94
Ferlin A, Zuccarello D, Zuccarello B, Chirico MR, Zanon GF, Foresta C. (2008). Genetic 
alterations associated with cryptorchidism. JAMA 300, 2271-2276. 
Ferlin A, Garolla A, Bettella A, Bartoloni L, Vinanzi C, Roverato A, Foresta C. (2005). 
Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. European 
Journal of Endocrinology, 152, 419-425. 
Foresta C, Zuccarello D, Garolla A, FerlinA. (2008). Role of hormones, genes, and 
environment in human cryptorchidism. Endocrine Reviews, 29, 560-580. 
Galan JJ, Guarducci E, Nuti F, Gonzales A, Ruiz M, Ruiz A, Krausz C. (2007). Molecular 
analysis of estrogen receptor alpha gene AGATA haplotype and SNP12 in 
European populations: potential protective effect for cryptorchidism and lack of 
association with male infertility. Human Reproduction, 22, 444-449. 
Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek N. (1989). Prevalence of carcinoma 
in situ and other histopathological abnormalities in testis of men with a history of 
cryptorchidism. Journal of Urology, 142, 998-1001. 
Hadźiselimović F, Geneto R, Emmons L. (2000). Elevated placental estradiol: a possible 
etiological factor of human cryptorchidism. Journal of Urology, 164, 1694-1695. 
Hadziselimowic F, Herzog B. (2001). Importance of early postnatal germ cell maturation for 
fertility of cryptorchid males. Hormone Research, 55, 6-10.  
Hejmej A, Bilińska B. (2008). The effects of cryptorchidism on the regulation of 
steroidogenesis and gap junctional communication in equine testes. Endocrinologia 
Polska, 59, 112-118. 
Huhtaniemi IT, Korenbrot CC, Jaffe RB. (1977). HCG binding and stimulation of testosterone 
biosynthesis in the human fetal testis. Journal of Clinical Endocrinology & Metabolism, 
4; 963-967. 
Jones WR. (1994). Gamete immunology. Human Reproduction, 9, 828-841. 
Kaki T, Sofikitis N. (1999). Effects of unilateral cryptorchidism on contralateral epididymal 
sperm quality, quantity and fertilizing capacity. Yonago Acta Medica, 42, 79-86. 
Kaleva M, Toppari J. (2005). Cryptorchidism: an indicator of testicular dysgenesis? Cell 
Tissue Research, 322, 167-172. 
Krause WK, Naz RK. (2009) Immune infertility. Springer-Verlag Berlin Heidelberg. 
Kurpisz M, Kasprzak M, Mazurkiewicz I. (1996). The easy formation of antisperm 
antibodies In prepubertal boys and the difficult humoral response in severe-
combined immunodeficiency mice. Fertility and Sterility, 66, 805-808. 
Läckgren G, Berg A. (2008). In vitro metabolism of progesterone by the human undescended 
testis. International Journal of Andrology, 6, 423-432. 
Lenzi A, Gandini L, Lombardo F, Cappa M, Nardini P, Ferro F. (1991). Antisperm antibodies 
in young boys. Andrologia, 23L 233-235. 
Martinetti M, Maghnie M, Salvaneschi L, Di Ninno N, Daielli C, Palladini G, Guccia M. 
(1992). Immunogenetic and hormonal study of cryptorchidism. Journal of Clinical 
Endocrinology & Metabolism, 74, 39-42. 
McGlynn K, Graubard B, Nam J, Stanczyk F,Longnecker M, Klebanoff M. (2005). Maternal 
hormone levels and risk of cryptorchism among populations at high and low risk 
of testicular germ cell tumors. Cancer Epidemiology, Biomarkers & Prevention 14, 1732-
1737. 
www.intechopen.com
 
Cryptorchidism and Steroid Hormones 
 
95 
Mieussed R, Fouda PJ, Vayse P, Guitard J, Moscovici J, Juskiewenski S. (1993). Increase in 
testicular temperature in case of cryptorchidism in boys. Fertility and Sterility, 59, 
1319-1321. 
Nguyen HT, Coakley F, Hricak H. (1999). Cryptorchidism: strategies in detection. European 
Radiology, 9, 336-343.  
Oettel M, Mukhopadhyay AK. (2004). Progesterone: the forgotten hormone in men? Aging 
Male, 7, 236-257. 
Quinton R, Duke VM, Robertson A, Krik JM, Matfin G, de Zoysa PA. (2001). Idiopathic 
gonadotropin deficiency: genetic questions addressed through phenotypic 
characterization. Clinical Endocrinology, 55, 163-174. 
Pierik FH, Burdorf A, Deddens JA, Juttmann RE, Weber R. (2004). Maternal and paternal 
risk factors for cryptorchidism and hypospodias: A case-control study in newborn 
boys. Environmental Health Perspectives, 112, 1570-1576. 
Przewratil P, Paduch D, Kobos J, Niedzielski J. (2004). Expression of estrogen receptor ǂ and 
progesterone receptor in children with undescended testicle previously treated 
with human chorionic gonadotropin. Journal of Urolology, 172, 1112-1116. 
Raivio T, Toppari J, Kaleva M, Virtanen H, Haavisto AM, Dunkel L, Jänne OA. (2003). 
Serum androgen bioactivity in cryptorchid and noncryptorchid boys during the 
postnatal reproductive hormone surge. Journal of Clinical Endocrinology & 
Metabolism, 88, 2597-2599. 
Sinisi AA, Pasquali P, Papparella A, Valente A, Orio F, Esposito D, Cobellis G, Cuomo A, 
Angelone G, Martone A, Fioretti GP, Bellastella A. (1998). Antisperm antibodies in 
cryptorchidism before and after surgery. Journal of Urology, 160:1835-1837. 
Skakkebaek N, Rajpert-De Meyts E, Main K. (2001). Testicular dysgenesis syndrome: an 
increasingly common develpomental disorder with environmental aspects. Human 
Reproduction, 16, 972-978. 
Thonneau P, Ducot B, Bujan L. Mieusset R, Spira A. (1996). Heat exposure as a hazard to 
male infertility. Lancet, 347, 204-205. 
Thorup J, Cortes D, Petersen BL. (2006). The incidence of bilateral cryptorchidism is 
increased and the fertility potential is reduced in sons born to mothers who have 
smoked during pregnancy. Journal of Urology, 176, 734-737. 
Tomboc M, Lee P, Mitwally M, Schneck F, Bellinger M, Witchel S. (2000). Insulin-like 
3/relaxin like factor gene mutations are associated with cryptorchidism. Journal of 
Clinical Endocrinology & Metabolism, 85 4013-4018. 
Toppari J, Kaleva M, Virtanen HE. (2001) Trends in the incidence of cryptorchidism and 
hypospodias, and methodological limitations of registry-based data. Human 
Reproduction Update, 7, 282-286. 
Toppari J, Kaleva M, Virtanen HE, Main KM, Skakkebaek NE. (2007). Luteinizing hormone 
in testicular descent. Molecular and Cellular Endocrinology, 269, 34-37. 
Toppari J, Virtanen H, Skakkebaek NE, Main KM. (2006). Environmental effects on 
hormonal regulation of testicular descent. Journal of Steroid Biochemistry & Molecular 
Biology, 102, 184-186. 
Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P. (1996). Male reproductive 
health and environmental xenoestrgens. Environmental Health Perspectives, 104: 741-
803. 
www.intechopen.com
 
Steroids – Basic Science 
 
96
Trisnar B, Res Muravec. (2009). Fertility potential after unilateral and bilateral orchidopexy 
for cryptorchidism. World Journal of Urology, 27, 513-519. 
Sasagawa I, Suzuki Y, Tateno T, Nakada T, Murowa K, Ogata T. (2000). CAG repeat length 
of the androgen receptor gene in Japanese males with cryptorchidism. Molecular 
Human Reproduction, 6, 973-975.  
Scorer CG. (1964). The descent of the testis. Archives of Disease in Childhood, 39, 605-609. 
Sharpe RM, Skakkebaek NE. (1993). Are oestrogens involved in falling sperm counts and 
disorders of the male reproductive tract? Lancet, 341, 1392-1396. 
Sultan C, Paris F, Terouanne B, Balaguer P, Georget V, Poujol N, Jeandel C, Lumbroso S, 
Nikolas J. (2001). Disorders linked to insufficient androgen action in male children. 
Human Reproduction Update, 7: 314-322. 
Suomi AM, Main Km, Kaleva M, Schmidt IM, Chellakooty M, Virtanen HE. (2006). 
Hormonal changes in 3-month-old cryptorchid boys. Journal of Clinical 
Endocrinology & Metabolism, 91, 953-958. 
Tsuji Y, Misuto M, Yasunami R, Sakata K, Shibahara H, Koyama K. (2000). HLA-DR and 
HLA-DQ gene typing of infertile women possessing sperm-immobilising antibody. 
Journal of Reproductive Immunology, 46, 31-38. 
Urry RL, Carrell DT, Starr NT, Snow BW, Middleton RG. (1994). The incidence of antisperm 
antibodies in infertility patients with a history of cryptorchidism. Journal of Urology, 
151, 381-383. 
Wenzler DL, Bloom DA, Park JM. (2004). What is the rate of spontaneous testicular descent 
in infants with cryptorchidism? Journal of Urology, 171, 849-851. 
Vidaeff A, Sever LE. (2005). In utero exposure to environmental estrogens and male 
reproductive health: a systematic review of biological and epidemiologic evidence. 
Reproductive Toxicology, 20, 5-20. 
Yoshida R, Fukami M, Sasagawa I, Hasegawa T, Kamatani N, Ogata T. (2005). Association of 
cryptorchidism with a specific haplotype of the estrogen receptor ǂ gene: 
implication for the susceptibility to estrogenic environmental endocrine disruptors. 
Journal of Clinical Endocrinology & Metabolism, 90, 4716-4721 
www.intechopen.com
Steroids - Basic Science
Edited by Prof. Hassan Abduljabbar
ISBN 978-953-307-866-3
Hard cover, 234 pages
Publisher InTech
Published online 11, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book explains the basic science of steroids and is targeted towards professionals engaged in health
services. It should be noted that medical science evolves rapidly and some information like the understanding
of steroids and their therapeutic use may change with new concepts quickly. Steroids are either naturally
occurring or synthetic fat-soluble organic compounds. They are found in plants, animals, and fungi. They
mediate a very diverse set of biological responses. The most widespread steroid in the body is cholesterol, an
essential component of cell membranes, and the starting point for the synthesis of other steroids. Since the
science of steroids has an enormous scope, we decided to put the clinical aspects of steroids in a different
book titled "Steroids-Clinical Aspects". The two books complete each other. We hope that the reader will gain
valuable information from both books and enrich their knowledge about this fascinating topic.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Marzena Kamieniczna, Anna Havrylyuk and Maciej Kurpisz (2012). Cryptorchidism and Steroid Hormones,
Steroids - Basic Science, Prof. Hassan Abduljabbar (Ed.), ISBN: 978-953-307-866-3, InTech, Available from:
http://www.intechopen.com/books/steroids-basic-science/cryptorchidism-and-steroid-hormones
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
